Only 41% of cancer survivors tested for HIV
the ONA take:
According to a new study published in the journal Preventing Chronic Disease, only 41% of cancer survivors in the United States under the age of 65 reported ever having a human immunodeficiency virus (HIV) test. Patients are typically tested for HIV when they are diagnosed with cancer or their cancer recurs in order to better coordinate cancer and HIV treatment and improve patient outcomes.
Until now, there has been no published data surrounding the proportion of cancer survivors in the United States who are tested for HIV. For the study, researchers analyzed data from the 2009 Behavioral Risk Factor Surveillance System to determine who had been tested for HIV and to identify factors associated with having had HIV testing.
Of the 41% of cancer survivors who had been tested, 72.2% were aged 25 to 34 years, 59.5% were non-Hispanic blacks, and 51.2% were cervical cancer survivors.
The highest proportion of cancer survivors tested for HIV were from Washington, D.C., and the lowest proportion were from Nebraska. Analyses showed cancer survivors were more likely to be tested for HIV if they were non-Hispanic black or Hispanic, younger, educated, not married or living with a partner, not disabled, and concerned about medical costs. Females, but not males, were more likely to be tested if they had an autoimmunodeficiency syndrome (AIDS)-defining illness.
Only 41% of cancer survivors in the U.S. under 65 reported ever having a HIV test.
Sign Up for Free e-newsletters
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Fosfomycin Effective Alternate for Febrile Neutropenia Prophylaxis
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Breast Implants Associated With Increased Risk of Breast Anaplastic Large-cell Lymphoma
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|